<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000761966"><TermName>PAD</TermName><TermDefinition><DefinitionText>An abbreviation for a chemotherapy combination used to treat multiple myeloma. It includes the drugs bortezomib, doxorubicin (Adriamycin), and dexamethasone. Also called PAD regimen.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>PAD</SpanishTermName><SpanishTermDefinition><DefinitionText>Abreviatura de una combinación de quimioterapia que se usa para tratar el mieloma múltiple e incluye los medicamentos bortezomib, doxorrubicina (Adriamycin) y dexametasona. También se llama régimen PAD.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2014-06-12</DateFirstPublished><RelatedInformation><RelatedDrugSummaryRef href="CDR0000762155">PAD</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
